QT
NTLA icon

Quantamental Technologies’s Intellia Therapeutics NTLA Stock Holding History

Quantamental Technologies’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,303
Closed -$56K – 1699
2019
Q1 		$56K Buy
3,303
+3,043
+1,170% +$45.4K 0.03% 825
2018
Q4 		$4K Buy
+260
New +$4.83K ﹤0.01% 1236

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantamental Technologies's NTLA Position: Q2 2019 in Review

Quantamental Technologies sold out of Intellia Therapeutics (NTLA) in Q2 2019, closing a stake of 3,303 shares — an estimated $56K sold.

Quantamental Technologies first reported a position in NTLA in Q4 2018 and held it in 2 quarters. The position peaked at $56K in Q1 2019. 144 funds tracked by Wall St. Rank hold NTLA as of Q2 2019.

  • Quantamental Technologies reported no remaining Intellia Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Quantamental Technologies sold 3,303 Intellia Therapeutics shares in Q2 2019, an estimated $56K.
  • Quantamental Technologies first reported a position in Intellia Therapeutics in Q4 2018 and held it in 2 quarters.
  • Quantamental Technologies's Intellia Therapeutics position peaked at $56K in Q1 2019.
  • 144 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2019.

Based on Quantamental Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.